Assure Holdings Announces the Establishment of a New Technologist Training and Education Program

Ramesh Vijay Named Director of Education

DENVER, Oct. 20, 2020 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (“IONM”), has announced a new education and training program for technologists. To lead this effort, the Company has appointed Ramesh Vijay to the newly created director of education position.

“Given the limited number of trained certified IONM technologists, estimated at approximately 5,000 individuals nationwide, building our own talent pipeline is essential to prepare for our anticipated growth and maintaining exceptional service,” said John A. Farlinger, Assure’s executive chairman and CEO. “To alleviate the bottleneck for technologists and foster the pipeline necessary for staffing our growth opportunities, Assure is developing our own technologist training program. We will be one of only a handful of IONM companies that are developing our own talent in this manner.”

Vijay will oversee Assure’s training program. This will include educating newly hired non board-certified technologists via didactic courses, clinical training and board preparation as well as the development of continuing education and advanced training for the clinical team. In addition, Vijay will spearhead Assure’s IONM clinical research projects, act as a Company representative for industry organizations including ASET, ASNM and ACNS, provide intermittent technologist case coverage, support business development efforts and serve as a member of the Clinical Leadership Team.

Farlinger continued, “Assure’s current and future success is rooted in the care we have taken to hire, develop, and retain the best, most dedicated technologists. The demonstrated expertise Ramesh brings to the organization supports our development plans and aligns with our principles.”

Farlinger concluded, “In addition, Ramesh will play an important role on research projects relating to IONM efficacy, safety, cost savings and improving patient outcomes that we are planning to launch through our collaboration with the surgeons at the internationally renowned Texas Back Institute. We envision numerous ways that this research will help Assure and the IONM industry as a whole.”

With an emphasis on training, patient care, clinical research and quality assurance, Mr. Vijay previously served as an educational leader and IONM technologist at multiple organizations including Specialty Care. Mr. Vijay has also worked as an instructor and researcher in higher education at Harvard Medical School, as an Assistant Professor in the Department of Pediatrics at the University of Louisville and most recently as an Assistant Professor in the Department of Pediatrics at the University of Chicago.

Mr. Vijay earned a Doctorate and Master’s Degree at the Aligarh Muslim University / All India Institute of Medical Sciences and a Master and Bachelor of Science from Bangalore University. He also completed a Postdoctoral Fellowship at the Stanford University School of Medicine.

Assure’s education and training program, which launched in the fourth quarter of 2020, will include lectures and classroom work, laboratory practicums, online instruction and operating room clinicals. It will also incorporate university internships and additional educational opportunities past the board certification, all with the goal of preparing these candidates to pass the CNIM certification exam and ultimately join Assure’s workforce. The education program will allow Assure to teach and mold these technologists as they prepare for a career in IONM and help the Company maintain rigorous quality control standards and the clinical excellence that Assure demands for the surgeons it supports and the patients it serves.

About Assure Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission’s Gold Seal of Approval®. For more information, visit the company’s website at www.assureneuromonitoring.com.

Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including but not limited to: comments with respect to the Company’s future growth; future actions of the Company and the expected effects of certain research projects relating to IONM. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the Company’s ability to continue to grow; the enrollment for the Company’s training program; the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and economic activity in general; and the risks and uncertainties discussed in our most recent annual and quarterly reports filed with the Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-287-3093
Scott.Kozak@assureiom.com

Released October 20, 2020